Researchers find a new pathological mediator of ALS

Researchers find a new pathological mediator of ALS
Aberrant axon morphologies in FUS-mutant ALS patient-derived MNs with Fos-B dysregulation. Credit: Masashi Aoki, Tohoku University

A research collaboration based in Japan has found a new pathological mediator of amyotrophic lateral sclerosis (ALS), which could have further implications for understanding the molecular breakdown that gives rise to the neurodegenerative disease that affects nearly half a million people around the world.

They published their results on June 28 in EBioMedicine, a journal issued by The Lancet.

Led by Masashi Aoki, Professor and chair of the Department of Neurology at Tohoku University Graduate School of Medicine and an author of the paper, the team in collaboration with Hideyuki Okano (Professor, of Keio University School of Medicine, Department of Physiology) focused on aberrant behavior in motor .

Motor neurons populate the base of the brain and along the spine. These cells are shaped like a hand with a palm and outstretched fingers, awaiting a signal from another cell. They take the signal and pulse it down their long arm, called an axon, to "touch" . The signal tells the muscle to flex or relax, but, in the case of patients with ALS, the axon divides and branches abnormally. Without connecting to its target, the axon can shrivel away. The message is lost, as is the ability to control the muscles.

Researchers still do not know how the message is disrupted, despite more than 25 genes identified as having a role in inherited ALS since 1993, according to Aoki.

Researchers find a new pathological mediator of ALS
Aberrant morphologies of zebrafish MN axons. Credit: Masashi Aoki, Tohoku University

"However, among all the causative genes of ALS, one gene, called FUS, was confirmed to locate at axon ends," Aoki said, referring to the "wrist" of the motor neuron, between the part of the cell that collects the signal and the part that sends the message to the muscles.

Aoki and the team obtained from a 43-year old patient with ALS and used those cells to sequence the genetic map of the motor neuron axons.

They found that a mutated version of FUS introduced what Aoki calls a toxic gain of function. It encouraged an abundance of another gene named Fos-B, which leads to axonal branching. Compare an axon to a grassy pathway. If there's a clear starting point and ending point, the path will become well-worn and clear. If there's one starting point and many ending points, no single path will emerge as the right one. With motor neurons, however, the signals can't forge ahead, and the paths will ultimately disappear completely.

To further test the Fos-B effect on motor neurons, Aoki and the team developed a Fos-B model of zebrafish, whose brain development bears a striking resemblance to that of humans. The abnormally higher-expressed Fos-B gene induced the over branching of motor neuronal axons.

"This result suggests a promising target for which ALS-linked mutations cause axonal refraction and degeneration- one of the earliest events in the disease," Aoki said, noting their results were in developing motor neurons. "We need more information to elucidate the relationship in mature neurons."

The researchers will continue to investigate their findings, delving deeper into the effect of Fos-B on developed .

Explore further

New method for studying ALS more effectively

More information: Tetsuya Akiyama et al. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons, EBioMedicine (2019). DOI: 10.1016/j.ebiom.2019.06.013
Journal information: EBioMedicine , The Lancet

Provided by Tohoku University
Citation: Researchers find a new pathological mediator of ALS (2019, September 3) retrieved 21 January 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments